PAKs |
P21-activated kinases |
PDA |
Pancreatic ductal adenocarcinoma |
TME |
Tumour microenvironment |
CSCs |
Cancer stem cells |
5-FU |
5-fluorouracil |
TKIs |
Tyrosine kinase inhibitors |
PFS |
Progression-free survival |
OS |
Overall survival |
MVD |
Microvessel density |
GTP |
Guanosine triphosphate |
MVI |
Microvessel integrity |
SEMA3A |
Semaphorin 3A |
SalB |
Salvianolic acid B |
HRG |
Histidine-rich glycoprotein |
RGS5 |
G-Protein Signalling 5 |
Cda |
Cytidine deaminase |
EMT |
Epithelial–mesenchymal transition |
VSMCs |
Vascular smooth muscle cells |
CSF2 |
Colony stimulating factor 2 |
HRG |
Heregulin β1 |
HIF-1α |
Hypoxia-inducible factor 1 alpha |
JMJD6 |
Jumonji domain-containing protein 6 |
MMP9 |
Matrix metalloproteinases 9 |
CAFs |
Cancer-associated fibroblasts |
PSCs |
Pancreatic stellate cells |
KO |
Knockout |
KD |
Knockdown |
GBM ECs |
Glioblastoma multiforme endothelial cells |
IHC |
Immunohistochemical |